Facet Hypertrophy | Diagnosis & Disease Information
Sep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or falls. 1
2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty: guideline summary.
Hydroxyapatite Crystal Deposition Disease (HADD)
Nov 15, 2022 · Hydroxyapatite deposition disease (HADD) is a condition where hydroxyapatite crystals accumulate in the soft tissues surrounding joints, leading to inflammation, tenderness, and pain. It primarily affects women around the age of 45 and commonly affects the glenohumeral joint in the shoulder. Other joints such as the hip, knee, elbow, wrist, and ...
3 Conditions That Looks Like Lyme Disease - Rheumatology Advisor
May 28, 2019 · We explore 3 conditions clinicians might mistake for the tick-borne illness. An accurate Lyme disease diagnosis is difficult. Not all patients present with its signature symptom, erythema migrans (EM), with or without the presence of a bull’s-eye-shaped rash. Other symptoms such as fever, chills, fatigue, and headache are nonspecific.
Calcium Pyrophosphate Deposition Disease (CPPD)
Oct 5, 2022 · Calcium pyrophosphate deposition disease (CPPD) is a crystal deposition arthropathy that involves the synovial and periarticular tissues, 1 often characterized by painful swelling in one or more joints. 2 Other names that have been traditionally used for CPPD are chondrocalcinosis, pyrophosphate arthropathy, and most especially, pseudogout. 3 ...
Managing Dental and Orofacial Manifestations of Systemic Lupus ...
Mar 4, 2020 · Importance of a Multidisciplinary Treatment Approach. The multisystem effect of SLE and the challenges presented by dental and orofacial manifestations call for a collaborative multidisciplinary team management approach whereby rheumatologists must carefully select treatment for patients with SLE to minimize risk for oral AEs and collaborate with dental and other practitioners for medical and ...
What Rheumatologists Need to Know About Cancer Risk in …
Apr 30, 2021 · In the United States, the lifetime risk of developing cancer is 1 in 3 individuals. 1 For patients with rheumatoid arthritis (RA), this risk may be increased due to the shared etiology between cancer and RA and the immunomodulatory nature of agents commonly used in RA treatment. 2 When determining appropriate therapeutic options for patients with RA and cancer, providers must make complex ...
Diagnosis & Disease Information - Rheumatology Advisor
Ankylosing Spondylitis. Ankylosing spondylitis (AS) is a chronic systemic inflammatory disorder affecting the axial skeleton, peripheral joints, entheses, eyes, skin, and intestines. It is characterized by inflammatory back pain, radiographic sacroiliitis, excess spinal bone formation, and a high prevalence of human leukocyte antigen (HLA)-B27 ...
Undifferentiated Connective Tissue Disease - Rheumatology Advisor
Aug 9, 2022 · Undifferentiated connective tissue disease (UCTD) is a diagnosis of exclusion. Patients who present with clinical and serolotical manifestations that suggest a systemic autoimmune disease but do not fulfill criteria for defined connective tissue disease (eg, systemic lupus erythematosus, scleroderma, myositis, rheumatoid arthritis, Sjogren's syndrome) are classified to have UCTD.
Drug-Induced Lupus | Diagnosis & Disease Information
Aug 4, 2022 · At least 46 drugs that are currently in use may cause drug-induced lupus. 4 The drugs most commonly associated with drug-induced lupus are hydralazine, procainamide, isoniazid, and quinidine. 2. The risk for developing lupus-like disease from any other drugs is low or very low. 2. There is a drug-induced lupus mnemonic to help keep the most ...